Reach Separations is celebrating its 5th anniversary with a record year of growth.
Reach Separations is celebrating its 5th anniversary with a record year of growth.
Headquartered at BioCity in Nottingham, UK, the company has carved out a niche for itself in the purification services space by supporting research chemists and scientists and establishing itself as a reliable chromatography purification provider.
“We are delighted with the progress the company has made since we started,” said Phil Abbott, Reach Separations Technical Director, and former Separation Science Group Leader at AstraZeneca. “Once we get the opportunity to work with a new chemistry group, they then tend to use us again and again as they know they can rely on our team” he continued.
The company has grown to employ 10 people and is currently recruiting for several new positions to support its expansion plans in 2017.
“We will certainly be on the lookout for talented scientists over the next year that we will train to become highly skilled chromatographers,” said Abbot. “We also have plans to make further investment in technology and equipment that will raise the bar even further,” he added.
Aimed at small molecule development projects, the company supports clients in the fields of chiral, reversed phase, and normal phase chromatography.
For more information on Reach Separations please visit: www.reachseparations.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.